1. Home
  2. DAIO vs GDTC Comparison

DAIO vs GDTC Comparison

Compare DAIO & GDTC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Data I/O Corporation

DAIO

Data I/O Corporation

N/A

Current Price

$3.06

Market Cap

23.4M

Sector

Industrials

ML Signal

N/A

Logo CytoMed Therapeutics Limited

GDTC

CytoMed Therapeutics Limited

HOLD

Current Price

$1.60

Market Cap

24.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
DAIO
GDTC
Founded
1969
2018
Country
United States
Singapore
Employees
N/A
N/A
Industry
Electrical Products
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
23.4M
24.8M
IPO Year
N/A
2023

Fundamental Metrics

Financial Performance
Metric
DAIO
GDTC
Price
$3.06
$1.60
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$5.22
N/A
AVG Volume (30 Days)
26.6K
79.1K
Earning Date
10-30-2025
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$22,701,000.00
$573,193.00
Revenue This Year
$9.14
$5.37
Revenue Next Year
$2.34
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
63.03
52 Week Low
$1.88
$1.50
52 Week High
$3.57
$4.05

Technical Indicators

Market Signals
Indicator
DAIO
GDTC
Relative Strength Index (RSI) 56.66 37.67
Support Level $2.86 $1.71
Resistance Level $3.20 $1.68
Average True Range (ATR) 0.14 0.12
MACD 0.05 -0.01
Stochastic Oscillator 74.56 15.32

Price Performance

Historical Comparison
DAIO
GDTC

About DAIO Data I/O Corporation

Data I/O Corp is a provider of programming, security deployment, security provisioning, and associated Intellectual Property protection and management solutions used in electronics manufacturing with flash memory, microcontrollers, and flash memory-based intelligent devices as well as secure element devices, authentication devices, and secure microcontrollers. It is engaged in focused on the design, manufacturing and sale of programming systems used by designers and manufacturers of electronic products. It has its geographic presence in the United States, Europe, and Asia and others. The company derives the majority of its revenue from Asia and others.

About GDTC CytoMed Therapeutics Limited

CytoMed Therapeutics Ltd is a pre-clinical biopharmaceutical company focused on harnessing its proprietary technologies to create novel cell-based immunotherapies for the treatment of human cancers. The company's segment include: the business of innate immune cell-based immunotherapy, pluripotent stem cell-based therapy and undertaking the research and development of immune cell and stem cell-based therapy; and the business of processing and banking of cells including cord blood stem cells, research and development on cord blood derived cell-based therapy. Geographically, the company operates in Singapore and Malaysia which is the majority revenue generator.

Share on Social Networks: